Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHOT: Atorvastatin for HCC Recurrence
NCT03024684Phase 4Active, not recruiting
- Sponsor
- Ditmanson Medical Foundation Chiayi Christian Hospital
- Start
- Jan 2017
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin in hepatocellular carcinoma (HCC), sponsored by Ditmanson Medical Foundation Chiayi Christian Hospital. Started Jan 2017; status: active, not recruiting.
02
Drugs
atorvastatin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT03024684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03024684.